FindTrial
Sign In

The Diagnostic value of Bronchoalveolar lavage fluid (BALF) GM test for invasive pulmonary aspergillus infection (IPA).

The Diagnostic value of Bronchoalveolar lavage fluid (BALF) GM test for invasive pulmonary aspergillus infection (IPA)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800014969
Enrollment
Unknown
Registered
2018-02-25
Start date
2018-04-01
Completion date
Unknown
Last updated
2018-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Invasive Pulmonary AspergillusInfection

Interventions

Gold Standard:Referring to the specialist’consensus of therapy and diagnosis of pneumomycosis in China in 2007. The selected patients were divided into non-IPA patients, diagnosis, clinical diagnosis
Index test:Galactomannan&#32
test&#32
of&#32
bronchoalveolar&#32
lavage&#32
fluid&#32

Sponsors

Second Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All patients who need bronchoalveolar lavage to obtain alveolar lavage fluid for bacterial culture, smear examination, acid fast staining and other clinical tests due to unclear clinical diagnosis.

Exclusion criteria

Exclusion criteria: 1. The clinical diagnosis has been clarified for patients undergoing bronchoalveolar lavage for the purpose of treatment of the disease; 2. Patients who are unwilling to cooperate or refuse to participate in this study.

Countries

Chian

Contacts

Public ContactLanyan Zhu

Second Xiangya Hospital of Central South University

zhulanyanhx@csu.edu.cn+86 13973136834

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026